SUV of (68Ga)DOTATOC-PET/CT predicts response probability of PRRT in neuroendocrine tumors

PurposeThe goal of our study was to quantify the expression of the somatostatin receptors (SSTR2) using the maximum standardized uptake value (SUVmax) of [68Ga]DOTA(0)-Phe(1)-Tyr(3)-octreotide (DOTATOC) positron emission tomography (PET)-computed tomography (CT) in liver metastases of patients with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kratochwil, Clemens (VerfasserIn) , Stefanova, Melsa (VerfasserIn) , Mavriopoulou, Eleni (VerfasserIn) , Afshar-Oromieh, Ali (VerfasserIn) , Mier, Walter (VerfasserIn) , Haberkorn, Uwe (VerfasserIn) , Giesel, Frederik L. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2015
In: Molecular imaging & biology
Year: 2014, Jahrgang: 17, Heft: 3, Pages: 313-318
ISSN:1860-2002
DOI:10.1007/s11307-014-0795-3
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1007/s11307-014-0795-3
Verlag, Volltext: https://link.springer.com/article/10.1007/s11307-014-0795-3
Volltext
Verfasserangaben:C. Kratochwil, M. Stefanova, E. Mavriopoulou, T. Holland-Letz, A. Dimitrakopoulou-Strauss, A. Afshar-Oromieh, W. Mier, U. Haberkorn, F.L. Giesel

MARC

LEADER 00000caa a2200000 c 4500
001 1559747056
003 DE-627
005 20240115091529.0
007 cr uuu---uuuuu
008 170614r20152014xx |||||o 00| ||eng c
024 7 |a 10.1007/s11307-014-0795-3  |2 doi 
035 |a (DE-627)1559747056 
035 |a (DE-576)489747051 
035 |a (DE-599)BSZ489747051 
035 |a (OCoLC)1340976109 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kratochwil, Clemens  |d 1978-  |e VerfasserIn  |0 (DE-588)134026276  |0 (DE-627)559871686  |0 (DE-576)300262787  |4 aut 
245 1 0 |a SUV of (68Ga)DOTATOC-PET/CT predicts response probability of PRRT in neuroendocrine tumors  |c C. Kratochwil, M. Stefanova, E. Mavriopoulou, T. Holland-Letz, A. Dimitrakopoulou-Strauss, A. Afshar-Oromieh, W. Mier, U. Haberkorn, F.L. Giesel 
246 3 0 |a 68 Ga 
246 3 3 |a SUV of (68 Ga)DOTATOC-PET/CT predicts response probability of PRRT in neuroendocrine tumors 
264 1 |c 2015 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online published: 16 October 2014 
500 |a Im Titel steht der Ausdruck (68 Ga) in eckiger Klammer, die Zahl 68 ist dabei hochgestellt 
500 |a Gesehen am 14.06.2017 
520 |a PurposeThe goal of our study was to quantify the expression of the somatostatin receptors (SSTR2) using the maximum standardized uptake value (SUVmax) of [68Ga]DOTA(0)-Phe(1)-Tyr(3)-octreotide (DOTATOC) positron emission tomography (PET)-computed tomography (CT) in liver metastases of patients with neuroendocrine tumors (NETs) prior to peptide receptor radiation therapy (PRRT) and compare the initial tumor uptake with the final treatment outcome.ProceduresSSTR2 expression of the 60 liver metastases in 30 NET patients was assessed at baseline and after PRRT by measuring SUVmax, tumor to spleen ratio (T/S ratio), and tumor to liver ratio (T/L ratio). Based on morphological changes and tumor size measured at baseline and follow-up contrast-enhanced CT (after three cycles of PRRT), lesions were divided into two groups by the following: (i) responding (n = 40) and (ii) non-responding (n = 20).ResultsStatistically significant differences were observed in the mean SUVmax for non-responding vs. responding lesions at baseline (18.00 ± 3.59 vs. 33.55 ± 4.62, p < 0.05) and for the mean T/S ratio (1.20 ± 0.37 vs. 1.90 ± 0.45, p < 0.05) and the mean T/L ratio (3.15 ± 0.53 vs. 4.97 ± 0.62, p < 0.05). Using the receiver operating characteristic curves, SUVmax was found a better metric than both T/L ratio and T/S ratio (area under the curve (AUC) of SUVmax 0.87; T/L ratio 0.78; T/S ratio 0.73) as a stratification criterion. Using a threshold value of >16.4 for SUVmax, the sensitivity and specificity in predicting responding lesions were 95 and 60 %, respectively.ConclusionWe propose a SUVmax cutoff of >16.4 from [68Ga]DOTATOC-PET-CT to select patients for PRRT. A T/L ratio >2.2 might present a scanner-independent criterion that enables the translation of our results to other institutions. However, the robustness of this arbitrary unit still needs to be evaluated with different PET scanners. 
534 |c 2014 
700 1 |a Stefanova, Melsa  |e VerfasserIn  |0 (DE-588)1135308233  |0 (DE-627)890264562  |0 (DE-576)489759475  |4 aut 
700 1 |a Mavriopoulou, Eleni  |e VerfasserIn  |0 (DE-588)1135219710  |0 (DE-627)890212619  |0 (DE-576)489718825  |4 aut 
700 1 |a Afshar-Oromieh, Ali  |d 1975-  |e VerfasserIn  |0 (DE-588)130260436  |0 (DE-627)496579711  |0 (DE-576)189580003  |4 aut 
700 1 |a Mier, Walter  |d 1966-  |e VerfasserIn  |0 (DE-588)12029026X  |0 (DE-627)69653567X  |0 (DE-576)292141599  |4 aut 
700 1 |a Haberkorn, Uwe  |d 1959-  |e VerfasserIn  |0 (DE-588)1022913905  |0 (DE-627)717331245  |0 (DE-576)366166352  |4 aut 
700 1 |a Giesel, Frederik L.  |d 1970-  |e VerfasserIn  |0 (DE-588)129031240  |0 (DE-627)387883878  |0 (DE-576)297457071  |4 aut 
773 0 8 |i Enthalten in  |t Molecular imaging & biology  |d Cham : Springer Nature Switzerland, 2002  |g 17(2015), 3, Seite 313-318  |h Online-Ressource  |w (DE-627)348231075  |w (DE-600)2079211-6  |w (DE-576)283406909  |x 1860-2002  |7 nnas  |a SUV of (68Ga)DOTATOC-PET/CT predicts response probability of PRRT in neuroendocrine tumors 
773 1 8 |g volume:17  |g year:2015  |g number:3  |g pages:313-318  |g extent:6  |a SUV of (68Ga)DOTATOC-PET/CT predicts response probability of PRRT in neuroendocrine tumors 
856 4 0 |u http://dx.doi.org/10.1007/s11307-014-0795-3  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://link.springer.com/article/10.1007/s11307-014-0795-3  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20170614 
993 |a Article 
994 |a 2015 
998 |g 129031240  |a Giesel, Frederik L.  |m 129031240:Giesel, Frederik L.  |d 910000  |d 911400  |e 910000PG129031240  |e 911400PG129031240  |k 0/910000/  |k 1/910000/911400/  |p 9  |y j 
998 |g 1135308233  |a Stefanova, Melsa  |m 1135308233:Stefanova, Melsa  |d 910000  |d 911400  |e 910000PS1135308233  |e 911400PS1135308233  |k 0/910000/  |k 1/910000/911400/  |p 2 
998 |g 1022913905  |a Haberkorn, Uwe  |m 1022913905:Haberkorn, Uwe  |d 910000  |d 911400  |e 910000PH1022913905  |e 911400PH1022913905  |k 0/910000/  |k 1/910000/911400/  |p 8 
998 |g 12029026X  |a Mier, Walter  |m 12029026X:Mier, Walter  |d 910000  |d 911400  |e 910000PM12029026X  |e 911400PM12029026X  |k 0/910000/  |k 1/910000/911400/  |p 7 
998 |g 130260436  |a Afshar-Oromieh, Ali  |m 130260436:Afshar-Oromieh, Ali  |d 910000  |d 911400  |e 910000PA130260436  |e 911400PA130260436  |k 0/910000/  |k 1/910000/911400/  |p 6 
998 |g 1135219710  |a Mavriopoulou, Eleni  |m 1135219710:Mavriopoulou, Eleni  |d 910000  |d 911400  |e 910000PM1135219710  |e 911400PM1135219710  |k 0/910000/  |k 1/910000/911400/  |p 3 
998 |g 134026276  |a Kratochwil, Clemens  |m 134026276:Kratochwil, Clemens  |d 910000  |d 911400  |e 910000PK134026276  |e 911400PK134026276  |k 0/910000/  |k 1/910000/911400/  |p 1  |x j 
999 |a KXP-PPN1559747056  |e 2971898970 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1559747056"],"doi":["10.1007/s11307-014-0795-3"]},"physDesc":[{"extent":"6 S."}],"relHost":[{"disp":"SUV of (68Ga)DOTATOC-PET/CT predicts response probability of PRRT in neuroendocrine tumorsMolecular imaging & biology","recId":"348231075","language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["4.2002 -"],"origin":[{"dateIssuedKey":"2002","publisherPlace":"Cham ; Amsterdam [u.a.]","publisher":"Springer Nature Switzerland ; Elsevier Science","dateIssuedDisp":"2002-"}],"title":[{"subtitle":"MIB ; the official journal of the Academy of Molecular Imaging","title_sort":"Molecular imaging & biology","title":"Molecular imaging & biology"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"volume":"17","text":"17(2015), 3, Seite 313-318","year":"2015","pages":"313-318","extent":"6","issue":"3"},"id":{"zdb":["2079211-6"],"issn":["1860-2002"],"eki":["348231075"]},"note":["Gesehen am 29.07.2020"]}],"note":["Online published: 16 October 2014","Im Titel steht der Ausdruck (68 Ga) in eckiger Klammer, die Zahl 68 ist dabei hochgestellt","Gesehen am 14.06.2017"],"recId":"1559747056","name":{"displayForm":["C. Kratochwil, M. Stefanova, E. Mavriopoulou, T. Holland-Letz, A. Dimitrakopoulou-Strauss, A. Afshar-Oromieh, W. Mier, U. Haberkorn, F.L. Giesel"]},"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"2015"}],"person":[{"role":"aut","family":"Kratochwil","display":"Kratochwil, Clemens","given":"Clemens"},{"role":"aut","family":"Stefanova","given":"Melsa","display":"Stefanova, Melsa"},{"family":"Mavriopoulou","display":"Mavriopoulou, Eleni","given":"Eleni","role":"aut"},{"family":"Afshar-Oromieh","given":"Ali","display":"Afshar-Oromieh, Ali","role":"aut"},{"given":"Walter","display":"Mier, Walter","family":"Mier","role":"aut"},{"family":"Haberkorn","given":"Uwe","display":"Haberkorn, Uwe","role":"aut"},{"role":"aut","display":"Giesel, Frederik L.","given":"Frederik L.","family":"Giesel"}],"titleAlt":[{"title":"SUV of (68 Ga)DOTATOC-PET/CT predicts response probability of PRRT in neuroendocrine tumors"}],"language":["eng"],"title":[{"title":"SUV of (68Ga)DOTATOC-PET/CT predicts response probability of PRRT in neuroendocrine tumors","title_sort":"SUV of (68Ga)DOTATOC-PET/CT predicts response probability of PRRT in neuroendocrine tumors"}]} 
SRT |a KRATOCHWILSUVOF68GAD2015